Group One Trading’s GSK GSK Stock Holding History

Group One Trading’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4M	Buy	242,400 +112,700	+87%	+$6.11M	0.03%	685
2025 Q4	$6.36M	Sell	129,700 -82,900	-39%	-$3.87M	0.01%	1282
2025 Q3	$9.18M	Sell	212,600 -48,300	-19%	-$1.89M	0.02%	969
2025 Q2	$10M	Buy	260,900 +38,700	+17%	+$1.48M	0.02%	808
2025 Q1	$8.61M	Sell	222,200 -147,900	-40%	-$5.41M	0.03%	715
2024 Q4	$12.5M	Buy	370,100 +1,100	+0.3%	+$39.6K	0.03%	578
2024 Q3	$15.1M	Buy	369,000 +87,900	+31%	+$3.6M	0.04%	401
2024 Q2	$10.8M	Sell	281,100 -100	-0%	-$4.21K	0.04%	408
2024 Q1	$12.1M	Sell	281,200 -71,700	-20%	-$2.96M	0.05%	360
2023 Q4	$13.1M	Buy	352,900 +6,400	+2%	+$230K	0.03%	532
2023 Q3	$12.6M	Buy	346,500 +71,500	+26%	+$2.54M	0.04%	404
2023 Q2	$9.8M	Buy	275,000 +107,900	+65%	+$3.87M	0.03%	523
2023 Q1	$5.95M	Sell	167,100 -5,900	-3%	-$206K	0.02%	750
2022 Q4	$6.08M	Sell	173,000 -91,500	-35%	-$3.05M	0.01%	1025
2022 Q3	$7.78M	Buy	264,500 +54,500	+26%	+$2.07M	0.02%	879
2022 Q2	$11.4M	Buy	210,000 +72,400	+53%	+$4M	0.02%	759
2022 Q1	$7.49M	Sell	137,600 -527,360	-79%	-$28.6M	0.01%	1214
2021 Q4	$36.7M	Buy	664,960 +271,920	+69%	+$14.1M	0.03%	403
2021 Q3	$18.8M	Buy	393,040 +186,560	+90%	+$9.37M	0.02%	648
2021 Q2	$10.3M	Sell	206,480 -81,760	-28%	-$3.93M	0.01%	1059
2021 Q1	$12.9M	Buy	288,240 +82,800	+40%	+$3.76M	0.02%	789
2020 Q4	$9.45M	Buy	205,440 +50,400	+33%	+$2.32M	0.02%	834
2020 Q3	$7.29M	Sell	155,040 -38,400	-20%	-$1.92M	0.02%	681
2020 Q2	$9.86M	Sell	193,440 -17,520	-8%	-$899K	0.05%	446
2020 Q1	$9.99M	Buy	210,960 +3,920	+2%	+$209K	0.08%	256
2019 Q4	$12.2M	Buy	207,040 +92,640	+81%	+$5.15M	0.08%	282
2019 Q3	$6.1M	Buy	114,400 +45,200	+65%	+$2.33M	0.05%	479
2019 Q2	$3.46M	Sell	69,200 -151,760	-69%	-$7.62M	0.03%	732
2019 Q1	$11.5M	Sell	220,960 -162,560	-42%	-$8.12M	0.13%	155
2018 Q4	$18.3M	Buy	383,520 +191,760	+100%	+$9.44M	0.16%	119
2018 Q3	$9.63M	Sell	191,760 -37,520	-16%	-$1.91M	0.08%	298
2018 Q2	$11.6M	Sell	229,280 -8,160	-3%	-$411K	0.1%	217
2018 Q1	$11.6M	Buy	237,440 +80,000	+51%	+$3.73M	0.12%	178
2017 Q4	$6.98M	Buy	157,440 +63,120	+67%	+$2.92M	0.05%	466
2017 Q3	$4.79M	Sell	94,320 -52,560	-36%	-$2.67M	0.04%	527
2017 Q2	$7.92M	Buy	146,880 +66,320	+82%	+$3.54M	0.08%	288
2017 Q1	$4.25M	Sell	80,560 -27,360	-25%	-$1.39M	0.05%	475
2016 Q4	$5.2M	Buy	107,920 +9,280	+9%	+$458K	0.05%	433
2016 Q3	$5.32M	Sell	98,640 -12,480	-11%	-$684K	0.06%	391
2016 Q2	$6.02M	Buy	111,120 +7,200	+7%	+$379K	0.07%	320
2016 Q1	$5.27M	Sell	103,920 -217,280	-68%	-$10.8M	0.07%	324
2015 Q4	$16.2M	Buy	321,200 +253,360	+373%	+$12.9M	0.19%	81
2015 Q3	$3.26M	Buy	67,840 +1,920	+3%	+$99.9K	0.05%	530
2015 Q2	$3.43M	Buy	65,920 +18,880	+40%	+$1.06M	0.05%	465
2015 Q1	$2.71M	Buy	47,040 +24,080	+105%	+$1.38M	0.04%	493
2014 Q4	$1.23M	Buy	22,960 +14,320	+166%	+$801K	0.02%	947
2014 Q3	$496K	Buy	+8,640	New	+$530K	0.01%	1634

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Group One Trading's GSK Position: Q3 2025 in Review

Group One Trading sold out of GSK (GSK) in Q3 2025, closing a stake of 38,563 shares — an estimated $1.51M sold.

Group One Trading first reported a position in GSK in Q2 2014 and held it in 24 quarters. The position peaked at $10.1M in Q2 2021. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Group One Trading reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Group One Trading sold 38,563 GSK shares in Q3 2025, an estimated $1.51M.
Group One Trading first reported a position in GSK in Q2 2014 and held it in 24 quarters.
Group One Trading's GSK position peaked at $10.1M in Q2 2021.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.